Recently, the CD133 molecule has been linked to tumor malignancy and invasiveness, and overexpression of EGFR and its ligands significantly contributes to the malignant phenotype and correlates with decreased survival in pancreatic cancer patients [46-49]. The gene discussed is PROM1; the disease is familial pancreatic carcinoma.